The New Oral Wegovy Pill: A 6-Month Review for Men

Oral Wegovy (semaglutide 25mg daily tablet) launched in U.S.

The Data

pharmacies on January 5, 2026 — the first FDA-approved oral GLP-1 for weight management. The OASIS 4 trial showed approximately 17% weight loss in adherent patients at 64 weeks, comparable to injectable Wegovy. Six months into real-world use, the picture for men is nuanced.

What This Means for You

The convenience factor is real — daily pill versus weekly injection eliminates the needle barrier that stops many men from starting. Manufacturer savings bring the starting dose to $149/month. But the daily empty-stomach dosing requirement (take on rising, wait 30 minutes before food or coffee) is a genuine lifestyle constraint that men with early work schedules or gym-first routines find challenging. Adherence data will be the story to watch.

The Practical Application

Injectable Wegovy's weekly dosing creates a 'set it and forget it' rhythm. Oral Wegovy demands daily compliance with specific conditions. For men who are needle-phobic but otherwise interested in GLP-1 treatment, oral Wegovy removes the primary barrier. For men who already manage weekly injections without issue, there's no compelling reason to switch formats..

Providers Worth Considering